CTX001

Welcome to the Brand page for “CTX001”, which is offered here for Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of sickle cell disease and b-thalassemi; pharmaceutical products and preparations, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “CTX001” is believed to be currently owned by “CRISPR Therapeutics AG”.

Owner:
CRISPR THERAPEUTICS AG
Owner Details
Description:
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of Sickle cell disease and B-thalassemi; pharmaceutical products and preparations, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders;
Categories: CELLS MEDICAL OR CLINICAL